Literature DB >> 34747194

One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis.

Supriya Arora1, Dmitrii S Maltsev2, Sumit Singh Randhir3, Niroj Kumar Sahoo4, Mahima Jhingan3, Deepika Parmeshwarappa5, Tarun Arora1, Alexei Kulikov2, Claudio Iovino6, Dinah Zur7, Gilad Fainberg7, Mohammed Nasar Ibrahim8, Filippo Tatti6, Ramkailash Gujar9, Ramesh Venkatesh10, Nikitha Reddy10, Ram Snehith10, Enrico Peiretti6, Marco Lupidi9, Jay Chhablani11.   

Abstract

PURPOSE: To evaluate the follow up and treatment outcome of central serous chorioretinopathy (CSCR) based on the new multimodal imaging-based classification and identify the predictors for anatomic and visual outcome.
METHODS: Retrospective, multicentric study on 95 eyes diagnosed with CSCR and a follow up of at least 12 months were included. Eyes with macular neovascularization, atypical CSCR or any other disease were excluded.
RESULTS: At the baseline, observation was advised to 70% eyes with simple CSCR whereas photodynamic therapy (PDT) was performed in 49% eyes with complex CSCR. Over the follow up, decrease in CMT was significantly higher in simple CSCR as compared to complex CSCR (P = 0.008) and the recurrences were significantly more in eyes with lower CMT at baseline (P = 0.0002). Median time of resolution of SRF was 3 months and 6 months in simple and complex CSCR respectively (P = 0.09). For the 12 months follow up, the median fluid free period was greater (P = 0.03) while number of interventions performed was lesser in eyes with simple CSCR as compared to complex CSCR (P = 0.006). Multiple regression analysis showed baseline best corrected visual acuity (BCVA) and baseline persistent SRF to be significantly predictive of BCVA and persistent SRF at 12 months (P < 0.0001, 0.04) respectively.
CONCLUSIONS: Complex CSCR more often required PDT, was associated with shorter fluid free interval and longer time for SRF resolution. Baseline BCVA and persistent SRF were predictive of final visual and anatomical outcome. The new multimodal imaging based classification is helpful in establishing objective criteria for planning treatment approaches for CSCR.

Entities:  

Keywords:  CME < retina; central serous chorioretinopathy < retina; retina – medical therapies < retina; retinal pathology/research < retina; techniques of retinal examination < retina

Mesh:

Year:  2021        PMID: 34747194     DOI: 10.1177/11206721211055018

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  3 in total

1.  Validation of central serous chorioretinopathy multimodal imaging-based classification system.

Authors:  Jay Chhablani; Francine Behar-Cohen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-20       Impact factor: 3.117

2.  OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy.

Authors:  Fang Zheng; Jingliang He; Zhitao Su; Ye Liu; Yufeng Xu; Lei Liu; Panpan Ye
Journal:  BMC Ophthalmol       Date:  2022-06-07       Impact factor: 2.086

3.  Predicting persistent central serous chorioretinopathy using multiple optical coherence tomographic images by deep learning.

Authors:  Donghyun Jee; Ji Hyun Yoon; Ho Ra; Jin-Woo Kwon; Jiwon Baek
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.